SCHEMBL4181128

SCHEMBL4181128

C1=C(C(Cc2ccccc2)Oc2ncccc2-c2nnc(N(Cc3ccccc3)C3=COCO3)[nH]2)OCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4188170 0.82 TUBB4A (0.30)
SCHEMBL4168453 0.77 AURKA (0.36)
SCHEMBL4170614 0.75 KDR (0.43)
SCHEMBL4169707 0.74 TUBB4A (0.39)
SCHEMBL4181723 0.73 CYP1A2 (0.42)
SCHEMBL4180846 0.72 TUBB4A (0.43)
SCHEMBL4181133 0.72 TUBB4A (0.44)
SCHEMBL4174903 0.72
SCHEMBL4173263 0.72 KDR (0.40)
SCHEMBL4181336 0.72 TUBB4A (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318438-A1 Heterocyclic compounds and their use as anticancer agents CHEN XIAOLING 2009-12-24 US disclosed
US-20090048301-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTICANCER AGENTS IMCLONE SYSTEMS INCORPORATED (US) 2009-02-19 US disclosed
WO-2005004818-A2 HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTICANCER AGENTS IMCLONE SYSTEMS INCORPORATED (US) 2005-01-20 WO disclosed